Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.
Phibro Animal Health Dividend Announcement
• Phibro Animal Health announced a quarterly dividend of $0.12 per ordinary share which will be made payable on 2024-12-18. Ex dividend date: 2024-11-27
• Phibro Animal Health annual dividend for 2024 was $0.48
• Phibro Animal Health annual dividend for 2023 was $0.48
• Phibro Animal Health's trailing twelve-month (TTM) dividend yield is 2.06%
• Phibro Animal Health's payout ratio for the trailing twelve months (TTM) is 111.70%
• Phibro Animal Health's dividend growth over the last five years (2018-2023) was 2.71% year
Phibro Animal Health Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-11-27 | $0.12 | quarterly | 2024-12-18 |
2024-09-04 | $0.12 | quarterly | 2024-09-25 |
2024-06-05 | $0.12 | quarterly | 2024-06-26 |
2024-03-05 | $0.12 | quarterly | 2024-03-27 |
2023-11-28 | $0.12 | quarterly | 2023-12-20 |
2023-09-05 | $0.12 | quarterly | 2023-09-27 |
2023-06-06 | $0.12 | quarterly | 2023-06-28 |
2023-02-28 | $0.12 | quarterly | 2023-03-22 |
2022-11-29 | $0.12 | quarterly | 2022-12-21 |
2022-09-06 | $0.12 | quarterly | 2022-09-28 |
2022-05-31 | $0.12 | quarterly | 2022-06-22 |
2022-03-01 | $0.12 | quarterly | 2022-03-23 |
2021-11-23 | $0.12 | quarterly | 2021-12-15 |
2021-08-31 | $0.12 | quarterly | 2021-09-22 |
2021-06-01 | $0.12 | quarterly | 2021-06-23 |
2021-03-02 | $0.12 | quarterly | 2021-03-24 |
2020-11-24 | $0.12 | quarterly | 2020-12-16 |
2020-09-01 | $0.12 | quarterly | 2020-09-23 |
2020-06-02 | $0.12 | quarterly | 2020-06-24 |
2020-03-03 | $0.12 | quarterly | 2020-03-25 |
2019-11-26 | $0.12 | quarterly | 2019-12-18 |
2019-09-03 | $0.12 | quarterly | 2019-09-25 |
2019-06-04 | $0.12 | quarterly | 2019-06-26 |
2019-03-05 | $0.12 | quarterly | 2019-03-27 |
2018-11-27 | $0.12 | quarterly | 2018-12-19 |
2018-09-04 | $0.10 | quarterly | 2018-09-26 |
2018-06-05 | $0.10 | quarterly | 2018-06-27 |
2018-03-06 | $0.10 | quarterly | 2018-03-28 |
2017-12-05 | $0.10 | quarterly | 2017-12-27 |
2017-09-01 | $0.10 | quarterly | 2017-09-27 |
2017-05-26 | $0.10 | quarterly | 2017-06-22 |
2017-02-27 | $0.10 | quarterly | 2017-03-22 |
2016-11-28 | $0.10 | quarterly | 2016-12-21 |
2016-09-02 | $0.10 | quarterly | 2016-09-28 |
2016-05-27 | $0.10 | quarterly | 2016-06-22 |
2016-02-29 | $0.10 | quarterly | 2016-03-23 |
2015-11-30 | $0.10 | quarterly | 2015-12-23 |
2015-08-31 | $0.10 | quarterly | 2015-09-23 |
2015-06-01 | $0.10 | quarterly | 2015-06-24 |
2015-03-02 | $0.10 | quarterly | 2015-03-25 |
2014-12-01 | $0.10 | quarterly | 2014-12-23 |
2014-08-29 | $0.10 | quarterly | 2014-09-24 |
Phibro Animal Health Dividend per year
Phibro Animal Health Dividend growth
Phibro Animal Health Dividend Yield
Phibro Animal Health current trailing twelve-month (TTM) dividend yield is 2.06%. Interested in purchasing Phibro Animal Health stock? Use our calculator to estimate your expected dividend yield:
Phibro Animal Health Financial Ratios
Phibro Animal Health Dividend FAQ
Other factors to consider when evaluating Phibro Animal Health as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Phibro Animal Health stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Phibro Animal Health's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Phibro Animal Health publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Phibro Animal Health distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Phibro Animal Health are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Phibro Animal Health sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Phibro Animal Health distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Phibro Animal Health declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Phibro Animal Health's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Phibro Animal Health's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.